HeartSciences extends debt maturity for 2026
HeartSciences Inc. amended its loan agreement with Front Range Ventures LLC to push back the repayment of principal and interest, refinancing terms originally set for 2023. The change aims to provide the company with additional financial breathing room and time to execute its corporate strategy before the new maturity deadline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed